News

The objective of the collaboration is to gain knowledge about the fundamental genetic causes of ALS. As per the agreement, Biogen Idec will fund the project at the

The double-blind, placebo-controlled study is designed to evaluate the safety of BB3 for the treatment of heart attack (acute myocardial infarction) in conjunction with standard-of-care and its efficacy

According to the collaboration, Novavax’s Phase II trial scheduled for second half of 2012 will be designed to evaluate the immune response to different doses of the vaccine

The injectable, sustained-release intravitreal insert releases sub-microgram levels of fluocinolone acetonide (FAc) for up to 36 months for the treatment of chronic DME. The company is developing an

NeuVax, a human epidermal growth factor receptor 2 (HER2)/neu peptide vaccine, consists of the E75 peptide derived from HER2 combined with the immune adjuvant granulocyte macrophage colony-stimulating factor

Ranibizumab is a topically active formulation of the anti-VEGF antibody, which utilizes OPKO proprietary drug delivery technology. OPKO chairman and chief executive officer Dr Frost said presently, ranibizumab

The Atorvastatin Calcium tablets, approved by the United States Food & Drug Administration (USFDA), are the bioequivalent generic version of Lipitor (atorvastatin calcium) tablets. According to IMS Health,

The FDA-approved Qsymia is used as a treatment for chronic weight management in adults who are obese or overweight with a weight-related comorbidity. Clinical studies have showed that

The patent-pending prenatal supplement is made up of key ingredients including biotin, B vitamins, vitamin D3, omega-3, iron, Coenzyme Q10 and choline. The flavorless Premama mix, which contains